‘First probable case of Monkeypox in West Virginia’ -WTRF.com Report
https://www.wtrf.com/west-virginia/first-probable-case-of-monkeypox-in-west-virginia/?utm_medium=referral&utm_campaign=socialflow&utm_source=t.co
‘First cases of monkeypox confirmed in South Carolina’ -News19 Report
https://www.wltx.com/article/news/health/confirmed-first-cases-of-monkeypox-in-south-carolina-midlands-lowcountry-dhec/101-710eb9a5-4f1c-44d0-9b35-0a59923a70f7
Horizon Therapeutics Receives FDA Approval For Uncontrolled Gout Candidate
The U.S. Food and Drug Administration (FDA) has approved Horizon Therapeutics’ (NASDAQ: HZNP) supplemental Biologics License Application (sBLA) for expanding the labeling to include KRYSTEXXA (pegloticase) injection co-administered with methotrexate, in patients with uncontrolled gout.
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours:
Inventiva Announces The Screening Of The First Patient In LEGEND, A Phase IIa Combination Trial With Lanifibranor And Empagliflozin In Patients With NASH And T2D
The Phase IIa Proof-of-Concept study is designed to assess the safety and efficacy of lanifibranor in combination with the SGLT2 inhibitor empagliflozin for the treatment of patients with non-cirrhotic non-alcoholic
‘Louisiana confirms first case of monkeypox’ -Nola.com
https://www.nola.com/news/healthcare_hospitals/article_42100524-fbf9-11ec-bd50-1719af89cf9b.html
The Daily Biotech Pulse: Merck’s Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
Here's a roundup of top developments in the biotech space over the last 24 hours: